SF3B1 and myelodysplastic syndrome: To determine whether XPO1 expression had an impact on survival in SF3B1 mutant patients, we analyzed the same MDS dataset [35], which showed that high XPO1 expression is significantly associated with a poor survival overall (Supplementary Fig. S1A) and specifically in the SF3B1 mutant populations (Fig. 1D).